Vanguard Personalized Indexing Management, LLC
Position in BFLY — Butterfly Network, Inc.
CIK 1767306
OAKLAND, CA
Position in BFLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$280,318
+$161,017 QoQ
Shares Held
33,292
+12.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#143
of 243 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in BFLY Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $87,495,534 across 36 Medical Devices names. BFLY ranks #23 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
235,178 | $21,340,051 | |
| 2 | SYK |
Stryker Corp
|
56,017 | $17,636,392 | |
| 3 | BSX |
Boston Scientific Corp
|
203,062 | $8,666,686 | |
| 4 | MDT |
Medtronic plc
|
107,336 | $8,396,895 | |
| 5 | EW |
Edwards Lifesciences Corp
|
88,167 | $7,975,586 | |
| 6 | PODD |
Insulet Corp
|
25,596 | $3,896,991 | |
| 7 | STE |
STERIS plc
|
13,703 | $2,885,440 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
39,442 | $2,524,682 |
All Filings in BFLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,318 | 33,292 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $119,301 | 29,530 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $86,279 | 22,705 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,955 | 19,148 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $39,692 | 19,846 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $44,859 | 19,675 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $62,802 | 20,129 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $36,072 | 20,380 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $17,394 | 20,683 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||